Our observation that hBD-2 is protective in ALD is in line with previous studies demonstrating that other AMPs such as CRAMP and alpha defensins ameliorate alcohol-associated liver injury, steatosis, and inflammation (Li et al., 2020; Zhong et al., 2020). This evidence concerns the gene ADSL and steatosis.